SCHEDULE: PEDEVCO Completes Merger, $35M PIPE, Kukes Board Exit

PEDEVCO Corp. announced the completion of significant mergers and a $35 million PIPE financing, alongside Dr. Simon Kukes' resignation from the board.

Summary

• PEDEVCO Corp. completed mergers with North Peak Oil & Gas, LLC and Century Oil and Gas Sub-Holdings, LLC on October 31, 2025, making them wholly-owned subsidiaries.
• The mergers involved the issuance of 10,650,000 shares of Series A Convertible Preferred Stock, which will convert into 106,500,000 common shares at a 10-to-1 ratio.
• A concurrent PIPE financing raised $35,000,004, with investors purchasing 6,363,637 Series A Preferred shares at $5.50 each, converting into 63,636,370 common shares.
• The SGK 2018 Revocable Trust, a family trust of Dr. Simon Kukes, invested $15,409,977 in the PIPE financing.
• Dr. Simon Kukes resigned as Executive Chairman and a board member effective October 31, 2025.
• The company's authorized common stock was increased to 300,000,000 shares from 200,000,000.
• Dr. Simon G. Kukes and SGK 2018 Revocable Trust collectively beneficially own 59,936,275 shares, representing 64.8% of the common stock, based on 92,519,352 shares outstanding as of November 4, 2025.

Sentiment

Score: 4

Explanation: While the company completed strategic mergers and secured financing, the substantial dilution from preferred stock conversion and the broad corporate opportunity waiver for key shareholders present significant concerns for existing common shareholders. The extensive protective provisions for preferred shareholders also limit management's flexibility.

Positives

• Completion of strategic mergers expands the company's operations and asset base.
• Successful PIPE financing raised $35,000,004, providing capital to pay off acquired companies' liabilities and cover transaction expenses.
• Juniper Shareholder and Dr. Kukes/SGK Trust have registration rights for their shares, facilitating future liquidity for these significant investors.
• Increased authorized common stock to 300,000,000 shares provides flexibility for future capital raises or strategic transactions.

Negatives

• Significant dilution from the conversion of Series A Preferred Stock (170.1 million new common shares) will substantially increase the outstanding share count from 92.5 million, negatively impacting existing common shareholders' per-share value.
• The waiver of corporate opportunities for Juniper and Dr. Kukes allows them to pursue competing ventures, potentially diverting valuable business opportunities from PEDEVCO.
• Dr. Kukes's resignation as Executive Chairman and board member marks a significant change in leadership and potentially influence.
• The Series A Preferred Stock holders have extensive protective voting rights, requiring majority approval for numerous operational and strategic decisions, which could limit the company's flexibility.

Risks

• Significant future dilution from the conversion of Series A Convertible Preferred Stock could negatively impact existing shareholders' per-share value.
• The waiver of corporate opportunities for certain shareholders (Juniper and Dr. Kukes) could lead to missed business opportunities for PEDEVCO.
• The extensive protective voting rights granted to Series A Preferred Stock holders could constrain management's ability to make timely strategic decisions without majority preferred shareholder approval.
• The timing of the Information Statement mailing and subsequent automatic conversion of preferred stock is not yet known, creating uncertainty regarding the exact date of dilution.

Future Outlook

The company plans to file an Information Statement (Schedule 14C) with the SEC within 20 days of the closing date (October 31, 2025) and a registration statement for resale of conversion shares within 45 days after the automatic conversion date. The Series A Preferred Stock will automatically convert into common stock 20 calendar days after the Information Statement is distributed to shareholders, and corporate actions (charter amendments) will become effective on the 21st day following the mailing date of the Information Statement.

Industry Context

The filing indicates a strategic expansion in the oil and gas sector through mergers, suggesting a growth-oriented strategy. The PIPE financing provides capital for this expansion and to manage liabilities of the acquired entities. The waiver of corporate opportunities is a notable governance point, often seen in companies with significant private equity or large individual investors who may have other ventures in the same industry.

Comparison to Industry Standards

• The 10-to-1 conversion ratio for preferred stock is a common mechanism for structuring such deals, but the sheer volume of new common shares (170.1 million) relative to existing shares (92.5 million) represents substantial dilution, which is higher than typical for many strategic acquisitions without a corresponding increase in market capitalization.
• The extensive protective provisions for Series A Preferred Stock holders, requiring majority approval for numerous operational and strategic decisions (e.g., M&A, capital expenditures over $250k, indebtedness over $500k), are quite broad and could be more restrictive than standard preferred stock terms, potentially indicating a strong influence by the new preferred shareholders (Juniper).
• The waiver of corporate opportunities for Dr. Kukes and Juniper is a governance practice that can be controversial, as it allows key stakeholders to pursue competing interests, which is not universally adopted and can be viewed as less favorable for minority shareholders compared to companies with stricter fiduciary duties.

Management Changes

Corporate Governance

Related Party Transactions

• The SGK 2018 Revocable Trust, a family trust of Dr. Simon Kukes (then Executive Chairman), invested $15,409,977 in the PIPE Financing.
• Dr. Simon Kukes and The SGK 2018 Revocable Trust are parties to the Support Agreement and Shareholder Agreement.
• The PEDEVCO A&R Charter includes a waiver of corporate opportunities specifically for Juniper and its affiliates and Dr. Simon Kukes.

Stakeholder Impact

• Shareholders (Common): Significant dilution from preferred stock conversion, potential for missed corporate opportunities due to waivers, reduced control due to preferred shareholder voting rights.
• Preferred Shareholders (Juniper/PIPE Investors): Gained significant influence and protective rights, along with a substantial equity stake, providing strong downside protection and upside potential.
• Management: Operational and strategic flexibility may be constrained by the extensive protective voting rights of preferred shareholders.
• Acquired Companies (NPOG, COG): Now wholly-owned subsidiaries of PEDEVCO, their liabilities were partially paid off by PIPE proceeds.

Next Steps

• PEDEVCO to prepare and file an Information Statement (Schedule 14C) with the SEC within 20 days after October 31, 2025.
• PEDEVCO to use commercially reasonable efforts to resolve SEC comments on the Information Statement.
• Information Statement to be distributed to shareholders.
• Automatic conversion of Series A Preferred Stock into common stock 20 calendar days after Information Statement distribution.
• Corporate actions (charter amendments) to become effective on the 21st day following the mailing date of the Information Statement.
• PEDEVCO to file a registration statement (Form S-3 or S-1) within 45 days after the Automatic Conversion Date to cover the resale of all Conversion Shares and other beneficially owned shares.

Key Dates

Recommendation

The substantial dilution from the Series A Preferred Stock conversion, coupled with the broad corporate opportunity waivers for key shareholders and the extensive protective voting rights granted to preferred shareholders, significantly diminishes the value and control for existing common shareholders. While the mergers and financing provide growth, the terms appear highly unfavorable for current common equity holders, suggesting a 'sell' recommendation for a seasoned investor looking to preserve capital and avoid significant value erosion.

Keywords

PEDEVCO, merger, PIPE financing, Series A Preferred Stock, common stock, Dr. Simon Kukes, beneficial ownership, corporate governance, oil and gas, energy, SEC filing, Schedule 13D, dilution, registration rights, corporate opportunities